Nitrous oxide

N/A

Report date: 2026/04/04 20:00:24
NME

Base Information

Drug NameNitrous oxide
Drug Alias NameN2O
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsEmergency Services, PsychiatricDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSwitzerland +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesCanadian Institutes Of Health Research (Cihr)Shaoxing Maternal And Child Health HospitalUniversity of Zurich +[7] 
Inactive CompaniesThe University Of Chicago
Active IndicationsEmergency Services, PsychiatricDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A